Artemis Investment Management’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-55,941
| Closed | -$5.95M | – | 204 |
|
|
2023
Q2 | $5.95M | Sell |
55,941
-5,401
| -9% | -$575K | 0.07% | 159 |
|
|
2023
Q1 | $18.3M | Sell |
61,342
-22,014
| -26% | -$6.56M | 0.22% | 114 |
|
|
2022
Q4 | $28.7M | Sell |
83,356
-2,550
| -3% | -$879K | 0.33% | 89 |
|
|
2022
Q3 | $16.3M | Sell |
85,906
-653
| -0.8% | -$124K | 0.19% | 121 |
|
|
2022
Q2 | $18.3M | Sell |
86,559
-2,705
| -3% | -$572K | 0.19% | 125 |
|
|
2022
Q1 | $29.9M | Buy |
89,264
+1,115
| +1% | +$373K | 0.24% | 107 |
|
|
2021
Q4 | $28.6M | Buy |
88,149
+1,883
| +2% | +$611K | 0.21% | 124 |
|
|
2021
Q3 | $41.9M | Buy |
86,266
+11,685
| +16% | +$5.67M | 0.33% | 89 |
|
|
2021
Q2 | $34.7M | Buy |
74,581
+10,089
| +16% | +$4.69M | 0.3% | 107 |
|
|
2021
Q1 | $44.4M | Buy |
64,492
+1,151
| +2% | +$792K | 0.42% | 72 |
|
|
2020
Q4 | $46.8M | Buy |
63,341
+734
| +1% | +$543K | 0.49% | 64 |
|
|
2020
Q3 | $43.4M | Buy |
62,607
+18,763
| +43% | +$13M | 0.54% | 51 |
|
|
2020
Q2 | $37.3M | Sell |
43,844
-5,341
| -11% | -$4.54M | 0.5% | 62 |
|
|
2020
Q1 | $17.4K | Sell |
49,185
-17,914
| -27% | -$6.33K | 0.03% | 92 |
|
|
2019
Q4 | $15.5M | Sell |
67,099
-7,288
| -10% | -$1.68M | 0.2% | 126 |
|
|
2019
Q3 | $8.37M | Buy |
74,387
+13,199
| +22% | +$1.48M | 0.11% | 184 |
|
|
2019
Q2 | $10.6M | Buy |
61,188
+627
| +1% | +$109K | 0.13% | 188 |
|
|
2019
Q1 | $9.67M | Sell |
60,561
-12,127
| -17% | -$1.94M | 0.11% | 197 |
|
|
2018
Q4 | $4.5M | Sell |
72,688
-5,740
| -7% | -$355K | 0.06% | 218 |
|
|
2018
Q3 | $9.7M | Buy |
78,428
+1,022
| +1% | +$126K | 0.11% | 195 |
|
|
2018
Q2 | $11.4M | Buy |
77,406
+1,754
| +2% | +$257K | 0.15% | 143 |
|
|
2018
Q1 | $12.2M | Buy |
+75,652
| New | +$12.2M | 0.19% | 129 |
|